TriSalus Life Sciences Presents Liver and Pancreatic Cancer Data at ASCO 2024
TriSalus Life Sciences, Inc. (NASDAQ:TLSI), an oncology company integrating its novel Pressure Enabled Drug Delivery™ (PEDD™) technology with immunotherapy to transform treatment for patients with liver